Aggerholm N - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2.

Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M. Safwat A, et al. Among authors: aggerholm n. Eur J Cancer. 2004 Jun;40(9):1412-7. doi: 10.1016/j.ejca.2004.01.037. Eur J Cancer. 2004. PMID: 15177501

Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma.

Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M. Safwat A, et al. Among authors: aggerholm n. J Exp Ther Oncol. 2003 Jul-Aug;3(4):161-8. doi: 10.1046/j.1359-4117.2003.01093.x. J Exp Ther Oncol. 2003. PMID: 14567287

A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma.

Safwat A, Schmidt H, Bastholt L, Fode K, Larsen S, Aggerholm N, von der Maase H. Safwat A, et al. Among authors: aggerholm n. Radiother Oncol. 2005 Nov;77(2):143-7. doi: 10.1016/j.radonc.2005.09.008. Epub 2005 Oct 10. Radiother Oncol. 2005. PMID: 16216360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters